#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3330	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2563	385.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1601	1601	C	499	C,A	416,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3330	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2563	385.1	0	HET	.	.	.	C207T,A	.	207	207	C	624	624	C	471	C,T,A	211,161,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5468	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3824	426.8	0	.	n	.	0	T695C	SNP	695	695	T	1203	1203	C	403	C,A	344,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5468	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3824	426.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2479	2479	C	524	C	435	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5468	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3824	426.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2553	2553	A	514	A,C	438,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5468	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3824	426.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3105	3105	C	426	C,T,A	347,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5468	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3824	426.8	0	HET	.	.	.	A1638G	.	1638	1638	A	2146	2146	A	515	A,G	346,88	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5468	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3824	426.8	0	HET	.	.	.	A2044G	.	2044	2044	A	2552	2552	A	512	A,G	218,221	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	540	folP	855	855	100.0	folP.l15.c4.ctg.1	1961	82.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1276	1278	AGC	112;112;111	A;G;C	93;95;93	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1260	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3820	98.9	1	SNP	p	S91F	1	.	.	271	273	TTC	864	866	TTC	125;127;126	T;T;C	105;104;107	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1260	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3820	98.9	1	SNP	p	D95G	1	.	.	283	285	GGC	876	878	GGC	128;129;130	G;G;C,T	107;109;106,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1260	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3820	98.9	1	SNP	p	G95N	0	.	.	283	285	GGC	876	878	GGC	128;129;130	G;G;C,T	107;109;106,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	504	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1704	88.6	1	SNP	p	G45D	0	.	.	133	135	GGC	600	602	GGC	140;140;138	G,T;G;C,A	113,1;116;116,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	318	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1414	67.1	0	.	n	.	0	A197.	DEL	197	197	A	761	761	A	124	A	107	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	104.4	1	SNP	p	D86N	0	.	.	256	258	GAC	841	843	GAC	134;135;135	G;A;C	115;114;120	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	104.4	1	SNP	p	R87W	0	.	.	259	261	CGT	844	846	CGT	136;136;136	C;G;T	121;120;119	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	104.4	1	SNP	p	R87I	0	.	.	259	261	CGT	844	846	CGT	136;136;136	C;G;T	121;120;119	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	104.4	1	SNP	p	S87R	1	.	.	259	261	CGT	844	846	CGT	136;136;136	C;G;T	121;120;119	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	104.4	1	SNP	p	S88P	0	.	.	262	264	TCC	847	849	TCC	137;136;135	T,A;C,A;C	120,1;120,1;120	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	858	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3167	81.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1762	1764	GGC	116;115;116	G;G;C	101;97;101	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1387	1389	GCC	127;128;128	G;C,T;C	102;96,1;104	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1390	1392	ATG	128;128;128	A;T,G;G	102;97,1;101	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1402	1404	ACC	128;128;128	A;C;C	103;104;105	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1402	1404	ACC	128;128;128	A;C;C	103;104;105	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1903	1905	ACC	113;113;113	A;C;C	101;99;96	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1957	1959	GCG	113;113;112	G;C;G	92;91;94	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1957	1959	GCG	113;113;112	G;C;G	92;91;94	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2080	2082	GGT	116;114;115	G;G,T;T	100;91,1;97	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2089	2091	AGC	116;116;116	A;G;C	101;100;103	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2724	93.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2107	2109	CCG	123;123;123	C;C;G	94;101;96	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1162	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3534	98.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1908	1910	CCG	108;108;108	C,A;C,G;G	85,1;87,1;87	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	584	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2339	74.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	835	835	C	81	C,A	68,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	84	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1480	16.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1206	1208	AAT	14;14;14	A;A;T	11;11;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	84	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1480	16.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1209	1211	AAT	14;14;14	A;A;T	11;11;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	84	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1480	16.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1233	1235	GCA	13;13;13	G;C;A	8;9;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	84	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1480	16.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1256	1258	GTA	13;13;13	G;T;A	10;9;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	84	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1480	16.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1265	1265	A	12	A	9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	588	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1938	90.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1120	1122	AGA	133;134;134	A;G;A,G	118;112;112,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	588	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1938	90.9	1	SNP	p	G120K	1	.	.	358	360	AAG	850	852	AAG	145;144;143	A;A;G,T	117;114;111,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	588	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1938	90.9	1	SNP	p	N121D	0	.	.	361	363	AAC	853	855	AAC	143;144;143	A;A;C	112;114;117	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	588	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1938	90.9	1	SNP	p	A121N	1	.	.	361	363	AAC	853	855	AAC	143;144;143	A;A;C	112;114;117	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2192	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5343	123.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	370	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1451	76.5	1	SNP	p	V57M	1	.	.	169	171	ATG	766	768	ATG	144;144;143	A,C;T;G,T	121,1;122;117,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
